# Jyong Biotech Ltd. (MENS)

> Source: Nexqual · https://nexqual.com/MENS · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Jyong Biotech Ltd. (MENS), nexqual.com/MENS" · informational, not investment advice.

**Price:** USD 1.98 (-3.41% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 2.05 · day 1.95–2.07 · 52w 1.43–63 · market cap $151M · NGM

## Key facts
- Analysts: None.
- Total return with dividends: 1Y -96.6% vs S&P 500 +18.1%; 5Y -75.3% vs S&P 500 +85.1%.
- Next earnings: 2026-11-12, EPS estimate USD —, revenue estimate $0K.

## Analysts
Consensus None.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2025-06-16) |
|---|---|---|
| Total return | -96.6% | -75.3% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -96.7% | -65.0% |
| Volatility (annualized) | 209.9% | 216.0% |
| Max drawdown | -97.6% (Oct 2025→Feb 2026) | -97.6% (Sep 2025→Feb 2026) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/MENS · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt